There are a few reports of side-effects of LHRHa treatment in childhood, th
e mechanisms of which remain little understood. Such effects can be local r
eactions: erythema, induration, wheal and sterile abscess formation, which
can be possible causes of therapy failure, There are negative effects on gr
owth velocity and final height requiring rhGH therapy or a suppressive trea
tment when bone age >13 years, Excessive weight gain can occur by various m
echanisms: menopausal-like phenomena, or LHRHa influence on hypothalamic an
d/or leptin-mediated control of body weight. Other possible adverse effects
involve increased ovarian volume with possible POS development; however, t
here is no evidence correlating LHRHa, hyperandrogenism and POS, The latter
appears related to CPP onset with pre-existing hyperandrogenism, although
lengthier follow-up is necessary to confirm this, Bone density decreases du
ring therapy, but final peak bone mass is in the normal range, Frequent tra
nsitory side-effects include headaches, hot flushes, depression and irregul
ar menses.